Cargando…
Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284358/ https://www.ncbi.nlm.nih.gov/pubmed/37040235 http://dx.doi.org/10.4103/ijmr.ijmr_233_22 |
| _version_ | 1785061383667187712 |
|---|---|
| author | Prabha, Praisy K. Prakash, Ajay Medhi, Bikash |
| author_facet | Prabha, Praisy K. Prakash, Ajay Medhi, Bikash |
| author_sort | Prabha, Praisy K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10284358 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102843582023-06-22 Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection? Prabha, Praisy K. Prakash, Ajay Medhi, Bikash Indian J Med Res Practice: Perspective Wolters Kluwer - Medknow 2023-01 2023-04-04 /pmc/articles/PMC10284358/ /pubmed/37040235 http://dx.doi.org/10.4103/ijmr.ijmr_233_22 Text en Copyright: © 2023 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Practice: Perspective Prabha, Praisy K. Prakash, Ajay Medhi, Bikash Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection? |
| title | Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection? |
| title_full | Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection? |
| title_fullStr | Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection? |
| title_full_unstemmed | Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection? |
| title_short | Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection? |
| title_sort | can changing the prodrug moiety in remdesivir be a life-saving strategy in covid-19 infection? |
| topic | Practice: Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284358/ https://www.ncbi.nlm.nih.gov/pubmed/37040235 http://dx.doi.org/10.4103/ijmr.ijmr_233_22 |
| work_keys_str_mv | AT prabhapraisyk canchangingtheprodrugmoietyinremdesivirbealifesavingstrategyincovid19infection AT prakashajay canchangingtheprodrugmoietyinremdesivirbealifesavingstrategyincovid19infection AT medhibikash canchangingtheprodrugmoietyinremdesivirbealifesavingstrategyincovid19infection |